Home Pilots Variantyx nabs $41.1M for tech-backed genomic analysis Pilots Variantyx nabs $41.1M for tech-backed genomic analysis By - February 14, 2022 75 0 Facebook Twitter Pinterest WhatsApp The company plans to use the funds to focus on the oncology space. RELATED ARTICLESMORE FROM AUTHOR Pilots Leidos, University of Pittsburgh spend $10M for AI disease detection Pilots HealthMed, Podimetrics partner to help high-risk patients with diabetes Pilots Digital dementia support project gets $2M federal funding and more briefs LEAVE A REPLY Cancel reply Please enter your comment! Please enter your name here You have entered an incorrect email address! Please enter your email address here Save my name, email, and website in this browser for the next time I comment. FOLLOW ME0FansLike0FollowersFollow0SubscribersSubscribe POPULAR ARTICLES Decentralized clinical trial platform Thread scoops up voice tech inVibe Pilots - January 20, 2022 0 SERI researchers develop AI tools for screening kidney disease, predicting age using eye photos Pilots - June 23, 2022 0 Swing Therapeutics scores $10.3M to support fibromyalgia DTx clinical trial Pilots - June 17, 2022 0 Digital health execs review the most noteworthy events of 2022 Pilots - December 29, 2022 0 Live tumor imaging company Elephas garners $55M Pilots - January 24, 2024 0 POPULAR CATEGORIESPilots2251Applications807Testing283Collaborations15GitHub3
